Tag: Risk

One Specific Blood Protein Can Identify Dementia Risk Decades Before Diagnosis : ScienceAlert

Unbeknownst to many, our bodies host numerous chemical biomarkers that can forecast our future health trajectories. These biomarkers

Inconsistent responses to risk management puzzling residents

Cromwell residents are expressing confusion over the varying strategies employed for risk management in their area. The New

Bayer Stock Jumps—Ruled Not Liable In Cancer Risk Case Involving Roundup Weedkiller

ToplineOn Thursday, the Supreme Court ruled in favor of Monsanto, previously an agrochemical giant, in a 7-2 decision.

One Stage of Sleep Seems Critical For Reducing The Risk of Dementia : ScienceAlert

It's widely recognized that a good night's sleep is essential for our overall health, but its significance extends

Shingles vaccine may lower dementia risk, new study finds

For older adults, receiving the shingles vaccine might reduce the risk of dementia. According to a recent study,

Covid vaccination cut risk of adverse heart events, large study finds

Recent Covid vaccinations are showing significant heart health benefits, as indicated by a new study. The research highlights

CME Group CEO Blasts Bitcoin Perpetual Futures, Warns of ‘2007’ Risk

CME Group (NASDAQ:CME) Chairman and CEO Terry Duffy recently expressed strong reservations about the Commodity Futures Trading Commission's

Trump ally admits political risk of Iran war at campaign event

Representative Ashley Hinson, who is anticipated to be the Republican nominee in Iowa’s crucial Senate race, recently expressed

New hormone protocol cut relapse risk in prostate cancer trial

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of

Florida hospital Medicaid funds, suicide risk: Morning Rounds

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up

Senator Cassidy’s Loss Shows Political Risk of Public Health Leadership

US Senator Bill Cassidy, Republican of Louisiana, attends a US Senate Finance Committee business meeting to consider the

Merck-Kelun lung cancer drug cut tumor progression risk by 65%

Adam Feuerstein is a senior writer and biotech columnist, focusing on drug development, business, Wall Street, and biotechnology.